Kiminori Fujimoto
Papers
1
Total Citations
2
H-Index
1
About
Kiminori Fujimoto is a leading authority in thoracic oncology, with a specialized focus on lung cancers, malignant pleural mesotheliomas, and thymic tumors. His major contributions lie in the development of evidence-based medical practice guidelines, particularly for thymic epithelial tumors, where he has helped shape diagnostic and therapeutic standards in Japan. As a key contributor to the Japan Lung Cancer Society’s 2024 guidelines, Fujimoto’s work synthesizes complex clinical evidence into actionable recommendations, directly influencing patient care and clinical decision-making. His most cited paper, summarizing recommendations for thymic epithelial tumors, has garnered 2 citations, reflecting its foundational role in guiding practitioners. Beyond guideline development, Fujimoto’s research integrates radiology, pathology, and oncology, advancing the multidisciplinary management of thoracic malignancies. His achievements include co-authoring national consensus documents that serve as benchmarks for quality care, ensuring that Japanese clinical practice aligns with global evidence. For students and researchers, Fujimoto exemplifies how rigorous evidence synthesis can translate into practical tools that improve outcomes in rare and complex thoracic cancers.
Research Focus
Key Achievements
Top Papers
- 1